Apart from the surface markers, blocking O-GlcNAcylation also decreased the cytokines tumor necrosis factor and interferon gamma (IFNG) and the death mediators, FasL, perforin, granzymes, and granulysin and compromised the cancer cell killing potential of both primary NK cells and NK-92 cells (61). The gene discussed is IFNG; the disease is cancer.